Advertisement

Topics

Companies Related to "More Pulmonary Hypertension Patients Have Access Pulmonary Hypertension" [Most Relevant Company Matches] RSS

09:21 EDT 25th September 2017 | BioPortfolio

Here are the most relevant search results for "More Pulmonary Hypertension Patients Have Access Pulmonary Hypertension" found in our extensive corporate database of over 50,000 company records.

Showing "More Pulmonary Hypertension Patients Have Access Pulmonary Hypertension" Companies 1–25 of 4,800+

Monday 25th September 2017

Sema4

Sema4 is a next generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics. Our team is creating practical tools that help patients, clinicians, and researchers better diagnose, treat, and prevent disease.


NewLink Genetics Corporation

NewLink Genetics Corporation is a biopharmaceutical company developing novel drugs and functional genomics solutions with a primary focus on cancer.The successful completion of the Human Genome Project signals a new age in medical discovery centered on protein research. The rapidly growing knowledge base of the human genome provides an unprecedented opportunity to launch a revolutionary paradigm ...

Friday 22nd September 2017

Apexus

Apexus is the nation’s leader in creating reliable health care solutions by enhancing access to medications and improving patient care. Apexus achieves these outcomes through innovative ambulatory pharmacy solutions and support of compliant 340B programs. In addition to serving as the HRSA-designated Prime Vendor for the 340B Drug Pricing Program, Ape...


Thursday 21st September 2017

Landos Biopharma, Inc.

Landos Biopharma, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a novel, locally-acting small molecule targeting inflammatory bowel disease (IBD) that is expected to enter clinical testing for Crohn’s...

Wednesday 20th September 2017

DermOne Dermatology Associates of Texas, P.A.

DermOne Dermatology Associates of Texas provides comprehensive medical, surgical, and cosmetic dermatology services. Our physicians excel at treating the full spectrum of conditions of the skin, hair and nails. Their commitment is to provide patients with the safest, most effective treatments and an unparalleled patient experience. DermOne affiliated physi...

Celcuity Inc.

We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. Our proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular activity dri...

Arcus Biosciences

Arcus Biosciences (“Arcus”) is a biotechnology company focused on the discovery and development of innovative cancer immunotherapies. Arcus was founded in 2015 by Terry Rosen and Juan Jaen, the co-founders of Flexus Biosciences, which in February 2015 was acquired by Bristol-Myers Squibb to access Flexus’s IDO inhibitor, which was in preclinical...

Tuesday 19th September 2017

Orphan Technologies

Orphan Technologies is dedicated to developing novel therapies to dramatically improve the lives of patients suffering from the rare disorder, homocystinuria and related diseases. OT-58, our lead drug development candidate, has been optimized as an enzyme replacement therapy for classical homocystinuria, a genetic disease characterized by debilitating card...

Cycle Pharmaceuticals

Cycle Pharmaceuticals is committed to changing the way that HT-1 is treated and managed around the world. Cycle Pharmaceuticals has worked for more than four years closely with physicians and patient groups to reduce the impact that HT-1 treatment has on patients’ lives. Nityr is the first formulation of nitisinone treatment that does not require refr...

IDbyDNA, Inc.

As a global leader in metagenomics, microbial genetics, and data analytics, IDbyDNA has a mission of enabling the identification of any microbe, from any sample, anywhere in the world. Leveraging advanced genome science and cutting-edge search technologies, IDbyDNA is leading the transformation of infectious disease diagnosis. IDbyDNA develops and commerci...

Monday 18th September 2017

PaceMate™

PaceMate™ was founded in 2015 by cardiac rhythm management industry professionals who experienced firsthand the overwhelming amount of device data inundating clinicians on a daily basis. The PaceMate™ team saw a need to develop innovative technology to streamline the device clinic, improve workflow, reduce medical errors, and take better care of ...

Centron

Centron is a full-service medical communications agency offering senior-level strategic expertise across a range of therapeutic areas in advertising, public relations, medical education and market access. Centron’s senior staff has over 300 years of combined healthcare experience and is committed to building bold, effective, and synergistic communicat...

Ncardia

Ncardia (www.ncardia.com) believes that stem cell technology will help to get better medicines to patients faster. The company develops, produces and commercializes highly predictive human cellular assay systems for safety and efficacy testing. The cardiac product portfolio encompasses a broad panel of hiPSC derived Cardiomyocytes (Pluricyte®, Cor.4UÂ...

Friday 15th September 2017

Rare Disease Communications®

Rare Disease Communications® is a health care communications and media company focused on the rare disease community and dedicated to raising awareness of rare diseases and orphan drugs so that patients will be diagnosed and treated more efficiently. Rare Disease Communications® is part of the Michael J. Hennessy Associates, Inc. family of businesses, ...

Thursday 14th September 2017

National Society of Genetic Counselors

NSGC is the leading voice, authority and advocate for the genetic counseling profession, representing more than 3,600 health care professionals. The organization is committed to ensuring that the public has access to genetic services. For more information, visit www.nsgc.org.

Weisman Children’s Rehabilitation Hospital and Voorhees Pediatric Facility

Weisman Children's Rehabilitation Hospital is a highly-acclaimed community-based pediatric specialty organization consisting of an acute rehabilitation hospital, outpatient rehabilitation centers and medical day care centers; focused solely on the needs of infants, children, teens and young adults in South Jersey and the Greater Philadelphia area. Weisman ...

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can l...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered by public and private insurers. Ambry Genetics is dedicated to scientific collaboration and the belief that human health should not be patented or owned.

Wednesday 13th September 2017

Oak Street Health

Oak Street Health is a rapidly growing, innovative company of community-based healthcare centers that provides higher quality health and wellness care that improves outcomes, manages medical costs, and provides an unmatched experience for adults on Medicare in medically underserved communities. By providing holistic, comprehensive, and integrated care righ...

TM3 Therapeutics

TM3 Therapeutics is focused on novel treatments for neurodegenerative and metabolic diseases by developing unique metabolite replacement therapies. Our goal is to improve survival outcomes and quality of life of patients with rare, genetic neurological diseases that have limited or no treatment options. Our clinical development program specifically targets...

Tuesday 12th September 2017

Creative Pharmacist

Co-founded by a community pharmacist and a technology expert in 2008, Creative Pharmacist, developer of the STRAND® clinical platform, is the U.S. market leader in helping pharmacists launch clinical services within their community. They support community pharmacists across the country in engaging patients with chronic disease, such as diabetes, through...

Monday 11th September 2017

Adello Biologics, LLC

Adello is a privately held, U.S.-based biotechnology company headquartered in Piscataway, NJ. The company's aim is to provide high-quality, affordable biosimilars to patients worldwide. Driven by a team of highly skilled industry veterans, Adello is advancing a pipeline of complex proteins and monoclonal antibodies with lead candidates in oncology and immu...

Friday 8th September 2017

RightEye LLC and VSP Global

As a doctor-governed company, VSP Global® exists to create value for members and opportunities for VSP network doctors. VSP Global’s complementary businesses include VSP® Vision Care, the only national not-for-profit vision benefits company, which provides access to eye care for its 84 million members through a network of 38,000 member eye docto...

Merck Merck

For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work wit...

Thursday 7th September 2017

Antidote Technologies Ltd

Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of participants, Antidote use cutting-edge technology to match the right patients with the right trials. Antido...


More From BioPortfolio on "More Pulmonary Hypertension Patients Have Access Pulmonary Hypertension"

Quick Search
Advertisement
 

Corporate Database Quicklinks